Advisory

Market entry, made clear.

Strategy deliverables, expert sessions, and in-country connections. Every engagement starts with a Market Brief.

Book a call →

Clients

Who it's for

BD leads, market access teams, and pharma or medtech leadership navigating emerging market entry, particularly in Africa, MENA, South and Southeast Asia.

Also CEOs of health SMEs who need a credible international expansion strategy without building a full internal team.

01

Start with a Market Brief

Run a free brief to establish the baseline

02

Scope the engagement

30-minute call to align on scope and timeline

03

We deliver

Written deliverable, deck, or session — your choice

04

You act

Analysis built for board rooms, partners, and market

Services

What we deliver

We start with a consultation to understand your product, your existing approvals, your timeline, and your organizational constraints. From there we scope an engagement and define clear deliverables together.

Strategy deliverables — written analysis and decks

01

Market Entry Strategy

Market shortlisting, feasibility analysis, and go/no-go recommendations grounded in verified market data.

02

Regulatory Landscape Mapping

Approval pathways, authority requirements, timeline and risk assessment by market, calibrated to your product type and existing clearances.

03

Market Entry Brief

Written analysis covering regulatory pathway, procurement structure, risk profile, and recommended entry sequence. PDF deliverable. 3-week turnaround.

04

Board & Investor Deck

Slide deck built on Vantro analysis, structured for leadership presentations and investor due diligence. Delivered in PowerPoint and PDF.

Engagements — speaking, workshops, and sessions

05

Speaking Engagements

Keynotes, panel contributions, and workshop facilitation on global health market access, emerging market entry, and health financing. Available for conferences, company offsites, and industry events.

06

Workshop Facilitation

Half-day or full-day sessions for BD, regulatory, and market access teams. Focused on market prioritisation, entry strategy, and cross-functional alignment.

Specialist services — economics, localisation, and connections

07

Health Economics and Access Analysis

Cost-effectiveness, HEOR framing, financing mechanisms, and blended-finance models for sustainable market access.

08

Product Localization

Adapting marketing, communications, and PR materials for local markets. Messaging frameworks grounded in local adoption realities, cultural context, and health system priorities.

09

In-Country Partner Introductions

Curated introductions to vetted local distributors, regulatory advisors, and market access partners in target markets.

Intensive engagements

10

Market Entry Sprint

Intensive 2-week engagement — market shortlisting, regulatory pathway, competitive landscape, and entry roadmap delivered end to end.

11

Advisory Retainer

Ongoing monthly engagement — market monitoring, regulatory updates, and strategic guidance as your pipeline evolves.

Track record

Selected engagements

Pharma · Africa and Asia

Designing a viable path to market for a vaccine platform across six emerging economies.

01

In four of six markets, donor co-investment was structurally available but required regulatory groundwork that most pharma companies skip — we built that foundation first.

02

UNICEF tender cycles created a sequencing opportunity in Southeast Asia that the client had not identified — aligning registration timing to procurement windows cut the commercialization timeline by eight months.

03

The final commercialization model was built around a blended structure: donor-anchored volume in public channels, commercial pricing in private, with a financing waterfall designed to sustain both.

Anonymized engagement

MedTech · Sub-Saharan Africa

Finding the right sequence: which African market to enter first, and why.

01

Kenya looked like the hardest market on paper. It turned out to be the most commercially viable — private channel concentration through Aga Khan and MP Shah outperformed the public tender route despite a 40/60 procurement split.

02

Nigeria's NAFDAC pathway added four to six months to the timeline versus CE reliance markets — running a parallel submission strategy compressed the total entry window without additional regulatory risk.

03

South Africa's entry recommendation was distributor-first through Netcare and Life Healthcare, building private sector evidence before approaching the public channel in year two.

Anonymized engagement

Multilateral · Global

Building the case for AI transformation in a global humanitarian response system.

01

The organisation assumed it was AI-ready. A structured assessment found no machine-readable data layer at the operational level — the real gap was infrastructure, not ambition.

02

Three investment scenarios were modeled from zero-budget optimisation using existing tools, to a phased hybrid model, to full donor-funded transformation — each with costed implementation plans and risk registers.

03

Benchmarked against six peer emergency centres globally, only two had deployed AI at operational scale — findings were presented to executive leadership with ROI analysis and a governance framework for responsible deployment.

Anonymized engagement

Ready to start?

Every engagement begins with a conversation. Tell us about your product, your target markets, and your timeline.

Book a call →

Or email hello@vantrohealth.com